ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2975

Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Pilloni L

Department Medical Sciences and Public Health, Pathology Unit, University of Cagliari, Italy

Biography

Dr.Pilloni L is currently working in the Department Medical Sciences and Public Health, Pathology Unit, University of Cagliari, Italy. Her research interest includes cytopathology, Pathology,  Health Sciences,Medical Sciences, histology, histopathology. She has done 14 publications in her field of study. 
Publications

Nivolumab Bullous Pemphigoid: Case Description and Literature Review

Nivolumab is a monoclonal antibody, belonging to the checkpoint inhibitors, recently approved for treatment of recurrent or metastatic non-small cell lung cancer, melanoma, and renal cell carcinoma. Although very efficacious, oncologic immunotherapy is associated with a new spectrum of dermatological adverse events, and spontaneous reporting is adv... Read More»

Anedda J, Atzori L, Rongioletti F and Pilloni L

: J Clin Exp Pathol, 9: 364

10.4172/2161-0681.1000364

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top